The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens
- 1 March 1992
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 41 (3-8) , 665-669
- https://doi.org/10.1016/0960-0760(92)90401-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Stimulatory effects of antiandrogens on LNCaP human prostate tumor cell growth, EGF-receptor level and acid phosphatase secretionThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- The androgen receptor: Functional structure and expression in transplanted human prostate tumors and prostate tumor cell linesThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgensBiochemical and Biophysical Research Communications, 1990
- Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: High affinity for progestagenic and estrogenic steroidsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1990
- Functional characterization of an androgen response element in the first intron of the C3(1) gene of prostatic binding proteinBiochemical and Biophysical Research Communications, 1989
- Gene regulation by steroid hormonesCell, 1989
- Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroidsInternational Journal of Cancer, 1988
- Androgen receptor-binding regions of an androgen-responsive geneMolecular and Cellular Endocrinology, 1987
- Regulation of prostatic steroid binding protein mRNAs by testosteroneMolecular and Cellular Endocrinology, 1985
- Steroid Hormone Regulation of Prostatic Acid Phosphatase Expression in Cultured Human Prostatic Carcinoma CellsBiological Chemistry Hoppe-Seyler, 1985